# DTE Energy Co: financial statements, quarterly

DTE · NYSE · CIK 936340 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dte.md) · [Financials](/companies/dte/financials.md) · [Filings](/companies/dte/filings.md) · [Insiders](/companies/dte/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dte/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [397](/filings/0000936340-24-000178.md) | [538](/filings/0000936340-24-000198.md) | [656 d](/filings/0000936340-26-000054.md) | [517](/filings/0000936340-25-000097.md) | [502](/filings/0000936340-25-000182.md) | [517](/filings/0000936340-25-000223.md) | [555 d](/filings/0000936340-26-000054.md) | [624](/filings/0000936340-26-000081.md) | [427](/filings/0000936340-25-000182.md) | [619](/filings/0000936340-25-000223.md) | [704 d](/filings/0000936340-26-000054.md) | [412](/filings/0000936340-26-000081.md) |
| Interest expense | $m | [192](/filings/0000936340-23-000169.md) | [200](/filings/0000936340-23-000189.md) | [208 d](/filings/0000936340-26-000054.md) | [218](/filings/0000936340-25-000097.md) | [233](/filings/0000936340-25-000182.md) | [252](/filings/0000936340-25-000223.md) | [248 d](/filings/0000936340-26-000054.md) | [250](/filings/0000936340-26-000081.md) | [256](/filings/0000936340-25-000182.md) | [271](/filings/0000936340-25-000223.md) | [279 d](/filings/0000936340-26-000054.md) | [293](/filings/0000936340-26-000081.md) |
| Income tax | $m | [34.0](/filings/0000936340-24-000178.md) | [22.0](/filings/0000936340-24-000198.md) | [63.0 d](/filings/0000936340-26-000054.md) | [21.0](/filings/0000936340-25-000097.md) | [36.0](/filings/0000936340-25-000182.md) | [(121)](/filings/0000936340-25-000223.md) | [30.0 d](/filings/0000936340-26-000054.md) | [(18.0)](/filings/0000936340-26-000081.md) | [1.0](/filings/0000936340-25-000182.md) | [(6.0)](/filings/0000936340-25-000223.md) | [111 d](/filings/0000936340-26-000054.md) | [(58.0)](/filings/0000936340-26-000081.md) |
| Net income | $m | [201](/filings/0000936340-24-000178.md) | [332](/filings/0000936340-24-000198.md) | [419 d](/filings/0000936340-26-000054.md) | [313](/filings/0000936340-25-000223.md) | [322](/filings/0000936340-25-000223.md) | [477](/filings/0000936340-25-000223.md) | [292 d](/filings/0000936340-26-000054.md) | [445](/filings/0000936340-26-000081.md) | [229](/filings/0000936340-25-000223.md) | [419](/filings/0000936340-25-000223.md) | [369 d](/filings/0000936340-26-000054.md) | [247](/filings/0000936340-26-000081.md) |
| Diluted EPS | $ per share | [0.97](/filings/0000936340-24-000178.md) | [1.61](/filings/0000936340-24-000198.md) | not reported | [1.51](/filings/0000936340-25-000097.md) | [1.55](/filings/0000936340-25-000182.md) | [2.30](/filings/0000936340-25-000223.md) | not reported | [2.14](/filings/0000936340-26-000081.md) | [1.10](/filings/0000936340-25-000182.md) | [2.01](/filings/0000936340-25-000223.md) | not reported | [1.19](/filings/0000936340-26-000081.md) |
| Basic EPS | $ per share | [0.97](/filings/0000936340-24-000178.md) | [1.61](/filings/0000936340-24-000198.md) | not reported | [1.51](/filings/0000936340-25-000097.md) | [1.56](/filings/0000936340-25-000182.md) | [2.30](/filings/0000936340-25-000223.md) | not reported | [2.14](/filings/0000936340-26-000081.md) | [1.10](/filings/0000936340-25-000182.md) | [2.02](/filings/0000936340-25-000223.md) | not reported | [1.19](/filings/0000936340-26-000081.md) |

- Revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000936340-23-000169.md) | [0.0](/filings/0000936340-23-000189.md) | [0.0](/filings/0000936340-25-000065.md) | [0.3](/filings/0000936340-24-000116.md) | [0.0](/filings/0000936340-24-000178.md) | [1.0](/filings/0000936340-24-000198.md) | [0.0](/filings/0000936340-26-000054.md) | [0.0](/filings/0000936340-25-000097.md) | [0.0](/filings/0000936340-25-000182.md) | [0.0](/filings/0000936340-25-000223.md) | [0.2](/filings/0000936340-26-000081.md) | [0.2](/filings/0000936340-26-000081.md) |
| Current assets | $bn | [3.2](/filings/0000936340-23-000169.md) | [3.4](/filings/0000936340-23-000189.md) | [3.5](/filings/0000936340-25-000065.md) | [3.8](/filings/0000936340-24-000116.md) | [4.5](/filings/0000936340-24-000178.md) | [5.6](/filings/0000936340-24-000198.md) | [3.6](/filings/0000936340-26-000054.md) | [3.6](/filings/0000936340-25-000097.md) | [3.5](/filings/0000936340-25-000182.md) | [3.8](/filings/0000936340-25-000223.md) | [4.3](/filings/0000936340-26-000081.md) | [4.4](/filings/0000936340-26-000081.md) |
| Total assets | $bn | [42.9](/filings/0000936340-23-000169.md) | [43.7](/filings/0000936340-23-000189.md) | [44.8](/filings/0000936340-26-000054.md) | [45.9](/filings/0000936340-24-000116.md) | [47.8](/filings/0000936340-24-000178.md) | [49.8](/filings/0000936340-24-000198.md) | [48.8](/filings/0000936340-26-000054.md) | [49.6](/filings/0000936340-25-000097.md) | [50.2](/filings/0000936340-25-000182.md) | [52.0](/filings/0000936340-25-000223.md) | [54.1](/filings/0000936340-26-000081.md) | [55.1](/filings/0000936340-26-000081.md) |
| Current liabilities | $bn | [3.6](/filings/0000936340-23-000169.md) | [4.0](/filings/0000936340-23-000189.md) | [5.9](/filings/0000936340-25-000065.md) | [5.0](/filings/0000936340-24-000116.md) | [6.5](/filings/0000936340-24-000178.md) | [6.8](/filings/0000936340-24-000198.md) | [5.1](/filings/0000936340-26-000054.md) | [4.2](/filings/0000936340-25-000097.md) | [3.8](/filings/0000936340-25-000182.md) | [3.3](/filings/0000936340-25-000223.md) | [5.4](/filings/0000936340-26-000081.md) | [4.6](/filings/0000936340-26-000081.md) |
| Long-term debt | $bn | not reported | not reported | [19.7](/filings/0000936340-24-000076.md) | not reported | not reported | not reported | [22.1](/filings/0000936340-25-000065.md) | not reported | not reported | not reported | [25.3](/filings/0000936340-26-000054.md) | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.5](/filings/0000936340-23-000169.md) | [1.2](/filings/0000936340-23-000189.md) | [1.3](/filings/0000936340-25-000065.md) | [0.3](/filings/0000936340-24-000116.md) | [0.6](/filings/0000936340-24-000178.md) | [1.0](/filings/0000936340-24-000198.md) | [1.1](/filings/0000936340-26-000054.md) | [0.5](/filings/0000936340-25-000097.md) | [0.6](/filings/0000936340-25-000182.md) | [0.2](/filings/0000936340-25-000223.md) | [0.9](/filings/0000936340-26-000081.md) | [0.0](/filings/0000936340-26-000081.md) |
| Shareholders' equity | $bn | [10.5](/filings/0000936340-23-000169.md) | [10.9](/filings/0000936340-23-000189.md) | [11.1](/filings/0000936340-25-000065.md) | [11.2](/filings/0000936340-24-000116.md) | [11.1](/filings/0000936340-24-000178.md) | [11.6](/filings/0000936340-24-000198.md) | [11.7](/filings/0000936340-26-000054.md) | [11.9](/filings/0000936340-25-000097.md) | [11.7](/filings/0000936340-25-000182.md) | [12.2](/filings/0000936340-25-000223.md) | [12.3](/filings/0000936340-26-000081.md) | [12.3](/filings/0000936340-26-000081.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [835 d](/filings/0000936340-24-000178.md) | [616 d](/filings/0000936340-24-000198.md) | [845 d](/filings/0000936340-26-000054.md) | [1,042](/filings/0000936340-25-000097.md) | [759 d](/filings/0000936340-25-000182.md) | [758 d](/filings/0000936340-25-000223.md) | [1,084 d](/filings/0000936340-26-000054.md) | [1,020](/filings/0000936340-26-000081.md) | [709 d](/filings/0000936340-25-000182.md) | [632 d](/filings/0000936340-25-000223.md) | [1,048 d](/filings/0000936340-26-000054.md) | [906](/filings/0000936340-26-000081.md) |
| Dividends paid | $m | [188 d](/filings/0000936340-24-000178.md) | [188 d](/filings/0000936340-24-000198.md) | [188 d](/filings/0000936340-26-000054.md) | [202](/filings/0000936340-25-000097.md) | [202 d](/filings/0000936340-25-000182.md) | [203 d](/filings/0000936340-25-000223.md) | [203 d](/filings/0000936340-26-000054.md) | [217](/filings/0000936340-26-000081.md) | [218 d](/filings/0000936340-25-000182.md) | [218 d](/filings/0000936340-25-000223.md) | [218 d](/filings/0000936340-26-000054.md) | [233](/filings/0000936340-26-000081.md) |
| Share repurchases | $m | [0.0 d](/filings/0000936340-23-000169.md) | [0.0 d](/filings/0000936340-23-000189.md) | [0.0 d](/filings/0000936340-25-000065.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [194](/filings/0000936340-23-000169.md) | [194](/filings/0000936340-23-000189.md) | [206](/filings/0000936340-24-000116.md) | [206](/filings/0000936340-24-000178.md) | [206](/filings/0000936340-24-000198.md) | [207](/filings/0000936340-25-000097.md) | [207](/filings/0000936340-25-000182.md) | [207](/filings/0000936340-25-000223.md) | [207](/filings/0000936340-26-000081.md) | [207](/filings/0000936340-25-000182.md) | [207](/filings/0000936340-25-000223.md) | [208](/filings/0000936340-26-000081.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 208,028,313 at 2026-03-31, from the cover of the [10-Q filed 2026-04-30](/filings/0000936340-26-000081.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.